Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
DFTX holding history
Definium Therapeutics, Inc. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DFTX overviewAll 13F holders of DFTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,298,946
- Value
- $61.1M
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,298,946 | $61.1M | 0.1% | +98,121+8.2% | Added | Holders |
| Q1 2026 | 1,200,825 | $22.7M | <0.1% | −1,774,877−59.6% | Reduced | Holders |
| Q4 2025 | 2,975,702 | $39.8M | <0.1% | +593,722+24.9% | Added | Holders |
| Q3 2025 | 2,381,980 | $28.1M | <0.1% | −1,039,244−30.4% | Reduced | Holders |
| Q2 2025 | 3,421,224 | $22.2M | <0.1% | +828,067+31.9% | Added | Holders |
| Q1 2025 | 2,593,157 | $15.2M | <0.1% | +91,766+3.7% | Added | Holders |
| Q4 2024 | 2,501,391 | $17.4M | <0.1% | +213,526+9.3% | Added | Holders |
| Q3 2024 | 2,287,865 | $13.0M | <0.1% | +127,662+5.9% | Added | Holders |
| Q2 2024 | 2,160,203 | $15.6M | <0.1% | +161,659+8.1% | Added | Holders |
| Q1 2024 | 1,998,544 | $18.8M | <0.1% | +1,998,544 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −11,545−100.0% | Sold out | Holders |
| Q3 2023 | 11,545 | $36.1K | <0.1% | +11,545 | New | Holders |